UT Southwestern Medical Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
UT Southwestern Medical Center brings 22 presentations to ASH 2026 in New Orleans. Its research spans sickle cell disease, myeloma, lymphoma and clonal hematopoiesis. It covers talquetamab response in myeloma with deletion 12p and CAR T-cell therapy use in relapsed B-cell lymphoma.
| Organization | ASH 2026 Attendance |
|---|---|
UT Southwestern Medical Center Dallas, TX | |
University of Texas academic medical center in Dallas, combining a medical school, research institutes and hospitals. | Symposium Fri Dec 11 3:00pm–6:00pm Myeloma Challenge! Test Your Knowledge of Updated Guidelines and Evidence-Based Practice Guideline-based myeloma care from smoldering disease to late relapse, including three- or four-drug regimens, residual disease testing, and newer immunotherapies. Oral Sat Dec 12 2:00pm–3:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Talk Sun Dec 13 4:30pm–5:45pm Choosing and Sequencing Anemia-Directed Treatment Options in Lower-Risk Myelodysplastic Syndromes Choosing and ordering newly approved and older anemia treatments for lower-risk myelodysplastic syndromes to get the best patient outcomes. Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at UT Southwestern Medical Center
Tell us what you sell and we’ll find the people at UT Southwestern Medical Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction